You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: January 2022 to July 2025

AbstractFullPdf
Jan 2022519541309
Feb 2022254259109
Mar 2022236238109
Apr 2022240251140
May 2022232234139
Jun 2022254258124
Jul 202231531991
Aug 202232633074
Sep 202228528990
Oct 2022317328122
Nov 2022247247109
Dec 202215615770
Jan 202313814077
Feb 202315115268
Mar 2023277278119
Apr 202316716879
May 202315415474
Jun 202314214254
Jul 202316816879
Aug 202315415540
Sep 202316316351
Oct 202317117163
Nov 202317717769
Dec 202322322475
Jan 2024219219163
Feb 202417517572
Mar 2024125128136
Apr 202411711798
May 202412012369
Jun 2024939380
Jul 202412412675
Aug 202423423495
Sep 2024116117806
Oct 2024818254
Nov 202411311570
Dec 2024159162317
Jan 202514615094
Feb 2025274277102
Mar 202512812879
Apr 202515215371
May 2025959657
Jun 2025636340
Jul 2025110
Total800181024812